Effects of a single dose of captopril on blood pressure and the renin-angiotensin-aldosterone system in normal subjects and hypertensive patients with various etiologies
Effect of a single dose of captopril on blood pressure and the renin-angiotensin-aldosterone (R-A-A) system was evaluated in 0 normal subjects and 11 hypertensive patients with various etiologies. Captopril was administered orally to normal healthy subjects and hypertensive patients on unrestricted...
Saved in:
Published in | Nihon Jinzo Gakkai shi Vol. 21; no. 11; pp. 1185 - 1192 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | Japanese |
Published |
Japan
Japanese Society of Nephrology
01.11.1979
|
Subjects | |
Online Access | Get full text |
ISSN | 0385-2385 1884-0728 |
DOI | 10.14842/jpnjnephrol1959.21.11_1185 |
Cover
Abstract | Effect of a single dose of captopril on blood pressure and the renin-angiotensin-aldosterone (R-A-A) system was evaluated in 0 normal subjects and 11 hypertensive patients with various etiologies. Captopril was administered orally to normal healthy subjects and hypertensive patients on unrestricted diet. Blood pressure was monitored for 4 hours. Blood was drawn at 0, 30 min., 1, 2, 3 and 4 hours for analysis of plasma renin activity (PRA), angiotensin I concentration (AI) and aldosterone concentration (PAC). Angiotensin II analogue (AIIA) test was done in each sub-jects after sodium depletion (40 mg f urosemide administration daily and mild sodium restricted diet for 3 days) Captopril in a dose of 100 mg caused no blood pressure change, increased PRA, AI and decreased PAC in normal subjects. When captopril was administered to patients with renovascular or malig-nant hypertension, blood pressure fell significantly for 4 hours, PRA and Al increased and PAC decreased for 4 hours. In low reninemic patients these paramenters showed little change. In all the subjects studied, change in mean blood pressure was inversely correlated with pre-treatment PRA value (y=-1.4×-2.8, r=0.85, p>0.001). Magnitude of blood pressure reduction by captopril was significantly correlated with that induced by angiotensin II antagonist (y=0.8×-5.0, r=0.93, p>0.001). From the results obtained, it is concluded that the acute blood pressure lowering effect of captopril in hyperreninemic hypertensive patients closely related to its effect on the suppression of R-A-A system. It may be useful to monitor the acute phase response of captopril to provide a prediction for the effectiveness of long term treatment of hypertension. |
---|---|
AbstractList | Effect of a single dose of captopril on blood pressure and the renin-angiotensin-aldosterone (R-A-A) system was evaluated in 0 normal subjects and 11 hypertensive patients with various etiologies. Captopril was administered orally to normal healthy subjects and hypertensive patients on unrestricted diet. Blood pressure was monitored for 4 hours. Blood was drawn at 0, 30 min., 1, 2, 3 and 4 hours for analysis of plasma renin activity (PRA), angiotensin I concentration (AI) and aldosterone concentration (PAC). Angiotensin II analogue (AIIA) test was done in each sub-jects after sodium depletion (40 mg f urosemide administration daily and mild sodium restricted diet for 3 days) Captopril in a dose of 100 mg caused no blood pressure change, increased PRA, AI and decreased PAC in normal subjects. When captopril was administered to patients with renovascular or malig-nant hypertension, blood pressure fell significantly for 4 hours, PRA and Al increased and PAC decreased for 4 hours. In low reninemic patients these paramenters showed little change. In all the subjects studied, change in mean blood pressure was inversely correlated with pre-treatment PRA value (y=-1.4×-2.8, r=0.85, p>0.001). Magnitude of blood pressure reduction by captopril was significantly correlated with that induced by angiotensin II antagonist (y=0.8×-5.0, r=0.93, p>0.001). From the results obtained, it is concluded that the acute blood pressure lowering effect of captopril in hyperreninemic hypertensive patients closely related to its effect on the suppression of R-A-A system. It may be useful to monitor the acute phase response of captopril to provide a prediction for the effectiveness of long term treatment of hypertension. |
Author | Gotoh, Motoki Maruyama, Anna Naka, Toru Higaki, Jitsuo Kumahara, Yuichi Takeshi, Hata Ogihara, Toshio Kanda, Takao Mikami, Hiroshi |
Author_xml | – sequence: 1 fullname: Kumahara, Yuichi organization: Department of Medicine and Geriatrics Osaka University Medical School – sequence: 1 fullname: Higaki, Jitsuo organization: Department of Medicine and Geriatrics Osaka University Medical School – sequence: 1 fullname: Maruyama, Anna organization: Department of Medicine and Geriatrics Osaka University Medical School – sequence: 1 fullname: Takeshi, Hata organization: Department of Medicine and Geriatrics Osaka University Medical School – sequence: 1 fullname: Mikami, Hiroshi organization: Department of Medicine and Geriatrics Osaka University Medical School – sequence: 1 fullname: Naka, Toru organization: Department of Medicine and Geriatrics Osaka University Medical School – sequence: 1 fullname: Ogihara, Toshio organization: Department of Medicine and Geriatrics Osaka University Medical School – sequence: 1 fullname: Kanda, Takao organization: Department of Medicine and Geriatrics Osaka University Medical School – sequence: 1 fullname: Gotoh, Motoki organization: Department of Medicine and Geriatrics Osaka University Medical School |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/396402$$D View this record in MEDLINE/PubMed |
BookMark | eNpdUcuO3CAQRNHmMdnsH-SAFCk3TwBjG47RavOQVsklOVttuz3GwuAAs6v5pPxl8M5oD7l0t7qqoFX1llw575CQD5ztuVRSfJpXNztcp-At15XeC77nvOVcVS_IjislC9YIdUV2rFRVIXJ5Q25iNB3jqmFl1cjX5FWpa8nEjvy9G0fsU6R-pECjcQeLdPARt0UPa_JrMJZ6Rzvr_UDXgDEeA1JwA00T0oDOuALcwfiELm6zzfqEIZ9N4ylPCzWOOh8WsDQeu_npv00_nVYMT6oHpCskgy4jjyZN9AGC8cdIMRlv_cFgfEdejmAj3lz6Nfn95e7X7bfi_ufX77ef74uZKyYKENiV5ai5klLpRmgmyqqW1QhqYKNSCupaIPQKtUKsR9RDp7tSgoaK864qr8nH87tr8H-OGFO7mNijteAwX9Q2MpvOGMvE9xfisVtwaLNRC4RTe7Y2wz_O8BwTHPAZhpBMb7H9L8ZWbBle6hbmM7GfILToyn_Y8KLi |
ContentType | Journal Article |
Copyright | Japanese Society of Nephrology |
Copyright_xml | – notice: Japanese Society of Nephrology |
DBID | CGR CUY CVF ECM EIF NPM 7X8 |
DOI | 10.14842/jpnjnephrol1959.21.11_1185 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
EISSN | 1884-0728 |
EndPage | 1192 |
ExternalDocumentID | 396402 article_jpnjnephrol1959_21_11_21_11_1185_article_char_en |
Genre | English Abstract Journal Article |
GroupedDBID | ALMA_UNASSIGNED_HOLDINGS JSF KQ8 OK1 RJT CGR CUY CVF ECM EIF NPM 7X8 |
ID | FETCH-LOGICAL-j1802-a2eb33f91844897290235645fa8d0f888a662eac8e98ee6fe9db9b34a9a511b53 |
ISSN | 0385-2385 |
IngestDate | Fri Jul 11 00:54:48 EDT 2025 Wed Feb 19 01:36:55 EST 2025 Wed Sep 03 06:29:13 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | true |
Issue | 11 |
Language | Japanese |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-j1802-a2eb33f91844897290235645fa8d0f888a662eac8e98ee6fe9db9b34a9a511b53 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 |
OpenAccessLink | https://www.jstage.jst.go.jp/article/jpnjnephrol1959/21/11/21_11_1185/_article/-char/en |
PMID | 396402 |
PQID | 74959000 |
PQPubID | 23479 |
PageCount | 8 |
ParticipantIDs | proquest_miscellaneous_74959000 pubmed_primary_396402 jstage_primary_article_jpnjnephrol1959_21_11_21_11_1185_article_char_en |
PublicationCentury | 1900 |
PublicationDate | 1979-Nov |
PublicationDateYYYYMMDD | 1979-11-01 |
PublicationDate_xml | – month: 11 year: 1979 text: 1979-Nov |
PublicationDecade | 1970 |
PublicationPlace | Japan |
PublicationPlace_xml | – name: Japan |
PublicationTitle | Nihon Jinzo Gakkai shi |
PublicationTitleAlternate | Jpn J Nephrol |
PublicationYear | 1979 |
Publisher | Japanese Society of Nephrology |
Publisher_xml | – name: Japanese Society of Nephrology |
References | 4) Gavras, H., Brunner, H. R., Turini, G.A., Kershaw, G. R., Tuft, C. P., Cuttelod, S., Gavras, I., Vukovich, R. A. & Mckinstry, D. N.: Antihypertensive effect of the oral angiotensin coverting enzyme inhibitor SQ 14225 in man. N. Engl. J. Med. 298: 991-995, 1978. 12) 荻原俊男,三上洋,円山アンナ,中透,桧垣実男,波多丈,中丸光昭,万代隆,神田敬夫,熊原雄一:レニン・アンジオテンシン系抑制剤総合臨牀28:316-322×979. 1) Ondetti,M. A., Rubin, B. & Cushman, D, W. Design of specific inhibitors of angiotensin-converting enzyme: new class of orally active antihypertensive agents. Science 196: 441-444, 1977. 9) Erdos, E. G. : Angiotensin I converting enzyme. Cir. Res. 36-247-255, 1975.10) Brunner, H. R., Waeber, B., Wauters, J. P., Turini, G., Mckinstry, D. & Gavras H,: In-nappropriate reamn secretion unmarked by captopril (SQ 14,225) in hypertension of chronic renal failure. Lancet 2 m 704-707, 1978. 11) Case, D. B., Atlas, S. A., Laragh, J. H., Sealey, J. E., Sullivan, P. A. & Mckinstry, D. N.: Clinical experience with blockade of the renin-angiotensin-aldosterone system by an oral convertingenzyme inhibitor (SQ 14,225, captpril) in hypertension patients. Progr. Cardiovasc. Dis. 21: 195-206, 1978. 15) Maruyama, A. & Ogihara, T. (in preparation 7) Ogihara, T., Yamameto, T., Doi, K., Omori, K. & Kumahara, Y. m Angiotensin I radioim-munoassay and its application for measurement of plasma reamn activity. Jpn. J. Nuci. Med. 10: 555-563, 1973. (In Japanese. 3) Bravo, E. L. & Tarazi, R. C,: Efficacy of ann orally-active converting enzyme inhibitor (SQ 14, 225) in the treatment of renovascular hypertension (RVH) in man. Kidney Int. 12 497, 1977. 6) Ogihara, T., Hata, T., Mikami, H., Nakamaru, M., Maruyama, A., Mandai, T. & Kumahara, Y.: Sodium depletion and blood pressure response to 1-sarcosine, 8-isoleucine angiotensin II in hypertension. Clin. Pharmacol. Ther. 23 566-572, 1978. 14) Case, D. B., Wallace, J. M,, Keim, H. J,, Weber, M., Sealy, J. & Laragh, J. H. : Possible role role of renin in hypertension as suggested by rm enin-sodium profiling and inhibition of converting enzyme, N. Engl. JB Med. 296 641 646, 1977. 2) Ferguson, R. K., Brunner, H. R., Turini, G.A., Gavras, H. & Mckinstry, D.N.: A specific orally active inhibitor of angiotensin-conver-ting enzyme in man. Lancet 1: 775-778, 1977. 8) Ogihara, T., Iinuma, K., Nishi, K., Arakawa, Y., Takagi, A., Kurata, K., Miyai, K. & Ku. mahara, Y.: A non-chromatographic non-extraction radioimmunoassay for serum aldos-terone. J. Clin. Endocrinol. Metab. 45: 736- 731, 1977. 13) Marks, A. D., Marks, D. B., Kanefsky, T. M., Adlin, V. E. & Channick, B. J. Enhanced adrenal responsiveness to angiotensin II in patients with low renin essential hypertension J. Clin. Endocrinol. Metab. 48. 266-270, 1979. 5) Brunner, H. R., Gavras, H., Waeber, B., Kershaw, G. R., Turini, G. A., Vukovich, R. A. & Mckinstry, D. N.: Oral angiotensin-conver-ting enzyme inhibitor in long-term treatment of hypertensive patients. Ann. Int. Med. 90: 19-23, 1979. |
References_xml | – reference: 14) Case, D. B., Wallace, J. M,, Keim, H. J,, Weber, M., Sealy, J. & Laragh, J. H. : Possible role role of renin in hypertension as suggested by rm enin-sodium profiling and inhibition of converting enzyme, N. Engl. JB Med. 296 641 646, 1977. – reference: 15) Maruyama, A. & Ogihara, T. (in preparation) – reference: 1) Ondetti,M. A., Rubin, B. & Cushman, D, W. Design of specific inhibitors of angiotensin-converting enzyme: new class of orally active antihypertensive agents. Science 196: 441-444, 1977. – reference: 9) Erdos, E. G. : Angiotensin I converting enzyme. Cir. Res. 36-247-255, 1975.10) Brunner, H. R., Waeber, B., Wauters, J. P., Turini, G., Mckinstry, D. & Gavras H,: In-nappropriate reamn secretion unmarked by captopril (SQ 14,225) in hypertension of chronic renal failure. Lancet 2 m 704-707, 1978. – reference: 13) Marks, A. D., Marks, D. B., Kanefsky, T. M., Adlin, V. E. & Channick, B. J. Enhanced adrenal responsiveness to angiotensin II in patients with low renin essential hypertension J. Clin. Endocrinol. Metab. 48. 266-270, 1979. – reference: 5) Brunner, H. R., Gavras, H., Waeber, B., Kershaw, G. R., Turini, G. A., Vukovich, R. A. & Mckinstry, D. N.: Oral angiotensin-conver-ting enzyme inhibitor in long-term treatment of hypertensive patients. Ann. Int. Med. 90: 19-23, 1979. – reference: 7) Ogihara, T., Yamameto, T., Doi, K., Omori, K. & Kumahara, Y. m Angiotensin I radioim-munoassay and its application for measurement of plasma reamn activity. Jpn. J. Nuci. Med. 10: 555-563, 1973. (In Japanese.) – reference: 6) Ogihara, T., Hata, T., Mikami, H., Nakamaru, M., Maruyama, A., Mandai, T. & Kumahara, Y.: Sodium depletion and blood pressure response to 1-sarcosine, 8-isoleucine angiotensin II in hypertension. Clin. Pharmacol. Ther. 23 566-572, 1978. – reference: 11) Case, D. B., Atlas, S. A., Laragh, J. H., Sealey, J. E., Sullivan, P. A. & Mckinstry, D. N.: Clinical experience with blockade of the renin-angiotensin-aldosterone system by an oral convertingenzyme inhibitor (SQ 14,225, captpril) in hypertension patients. Progr. Cardiovasc. Dis. 21: 195-206, 1978. – reference: 3) Bravo, E. L. & Tarazi, R. C,: Efficacy of ann orally-active converting enzyme inhibitor (SQ 14, 225) in the treatment of renovascular hypertension (RVH) in man. Kidney Int. 12 497, 1977. – reference: 12) 荻原俊男,三上洋,円山アンナ,中透,桧垣実男,波多丈,中丸光昭,万代隆,神田敬夫,熊原雄一:レニン・アンジオテンシン系抑制剤総合臨牀28:316-322×979. – reference: 2) Ferguson, R. K., Brunner, H. R., Turini, G.A., Gavras, H. & Mckinstry, D.N.: A specific orally active inhibitor of angiotensin-conver-ting enzyme in man. Lancet 1: 775-778, 1977. – reference: 8) Ogihara, T., Iinuma, K., Nishi, K., Arakawa, Y., Takagi, A., Kurata, K., Miyai, K. & Ku. mahara, Y.: A non-chromatographic non-extraction radioimmunoassay for serum aldos-terone. J. Clin. Endocrinol. Metab. 45: 736- 731, 1977. – reference: 4) Gavras, H., Brunner, H. R., Turini, G.A., Kershaw, G. R., Tuft, C. P., Cuttelod, S., Gavras, I., Vukovich, R. A. & Mckinstry, D. N.: Antihypertensive effect of the oral angiotensin coverting enzyme inhibitor SQ 14225 in man. N. Engl. J. Med. 298: 991-995, 1978. |
SSID | ssib018703574 ssib004261733 ssib058493074 ssib000833381 ssib002004354 ssib005879731 ssib039893136 ssib008531636 ssib038076193 ssj0000696431 ssib000940323 ssib002822005 ssib038586121 ssib047305546 |
Score | 1.2697217 |
Snippet | Effect of a single dose of captopril on blood pressure and the renin-angiotensin-aldosterone (R-A-A) system was evaluated in 0 normal subjects and 11... |
SourceID | proquest pubmed jstage |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 1185 |
SubjectTerms | Adult Aldosterone - blood Angiotensin I - blood Angiotensins - blood Blood Pressure - drug effects Captopril - administration & dosage Captopril - pharmacology Humans Hypertension - physiopathology Male Proline - analogs & derivatives Renin - blood |
Title | Effects of a single dose of captopril on blood pressure and the renin-angiotensin-aldosterone system in normal subjects and hypertensive patients with various etiologies |
URI | https://www.jstage.jst.go.jp/article/jpnjnephrol1959/21/11/21_11_1185/_article/-char/en https://www.ncbi.nlm.nih.gov/pubmed/396402 https://www.proquest.com/docview/74959000 |
Volume | 21 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
ispartofPNX | The Japanese Journal of Nephrology, 1979, Vol.21(11), pp.1185-1192 |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1bb9MwFLa2ISFeEIghxtXSeKsymthJ7EeEBmOIPXXS3iIncdaEklRdiwT_iH_JOb4k2cYQTLxETVonbo4_n-_Y50LI6zIROWh1FiQFZwFXqQ6UBCJXTRVPqyRNtMTY4c8nydEpPz6Lz7a290deS5t1flD8-G1cyW2kCtdArhgl-w-S7W8KF-AzyBeOIGE4_pWMDwdnDDVBox-joDq7Ol-o5bpbruoFbgcY9_SJ8Xn1GwbGtVC3dRuo9rzujCM7fF6UGPWx6oB72iTPuCDSIrFdTC42eWOeh-3nYMCuvPu7y87qQuW-gf2NnrV6bWJhvJtiMwzMY1DRWPpyMuLDJxrG1aVFfnT_xnzSRk1s6mJejxbKla23fVyvLzbdsK6-2nxXX-1acdv2KmemvuiLuS3QbYPx3FJHKFPpYv56NeT75h1ar_fNRYKJOAAqYnfLtZ3YheDBNHWB6G7mt7HZfoSHo3kczK54xAnC0Bbsu6ZvuOCYwLZZtk1re4LJeg6iEFRRNtzkUkJvN1yyK42yCFu4IzbN_A8x_g6G-za5E6Wp9UX4-GnMoRkbB1NLPmVjToubveOceUAJr5QoCNMR549FiuXM-nPgc8DZe84awgTP4sFmwIIFYISz4TwWmJWuP5fAiMOhPU8xx9ywBgEEWDKfkMnSJ0wRZypdejneJfv-Zb-5-VUDh2zAojrXNxuLhjTOHpD7bnTTt_YVPyRbjXpEfjrY0q6iilrYUoQtXuhhS7uWGthSD1sKsKMAW_pH2FILW1q31MKWetia9mPYUg9birClDrZ0gO0uOX1_OHt3FLiKKUGDmRwDFemcsUqGgnMhwW7GbFYJjyslymklhFBJEgHVEloKrZNKyzKXOeNKKjC88pg9JjstdPUJoejBAfdJ1LSA75NQ5EUpSqZZXBa8iJI98sG-7Wxp0-Jktx3Xe-SVF1cGug03LAHm8H-zlEtT1HiP7Fop9s9iMEam0dP_1odn5N4w4TwnO-vVRr8Aa2OdvzRo-wXskyU7 |
linkProvider | Flying Publisher |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Effects+of+a+single+dose+of+captopril+on+blood+pressure+and+the+renin-angiotensin-aldosterone+system+in+normal+subjects+and+hypertensive+patients+with+various+etiologies&rft.jtitle=The+Japanese+Journal+of+Nephrology&rft.au=Kumahara%2C+Yuichi&rft.au=Higaki%2C+Jitsuo&rft.au=Maruyama%2C+Anna&rft.au=Takeshi%2C+Hata&rft.date=1979-11-01&rft.pub=Japanese+Society+of+Nephrology&rft.issn=0385-2385&rft.eissn=1884-0728&rft.volume=21&rft.issue=11&rft.spage=1185&rft.epage=1192&rft_id=info:doi/10.14842%2Fjpnjnephrol1959.21.11_1185&rft.externalDocID=article_jpnjnephrol1959_21_11_21_11_1185_article_char_en |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0385-2385&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0385-2385&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0385-2385&client=summon |